Dr. Naranjan Dhalla, Principal Investigator of Experimental Cardiology at the Institute of Cardiovascular Sciences and Distinguished Professor at the Max Rady College of Medicine, University of Manitoba, has been named a 2024 Highly Ranked Scholar by ScholarGPS. This prestigious honour places Dr. Dhalla in the top 0.05% of all scholars worldwide, a testament to his exceptional career, marked by prolific publications, high-impact research, and outstanding contributions to scientific knowledge.

A Lifetime of Impactful Research

ScholarGPS uses a rigorous, quantitative ranking system to evaluate scholars, institutions, and academic programs globally. Their rankings are based on research productivity (publication counts), impact (citation counts), and quality (h-index), offering an objective benchmark of scholarly excellence. Dr. Dhalla’s “Lifetime” ranking reflects the incredible breadth and depth of his work over his entire career.

Here’s a closer look at Dr. Dhalla’s remarkable 2024 ScholarGPS rankings:

• #7,961 Overall (All Fields)
• #1,994 Medicine
• #2 Diabetic cardiomyopathy
• #5 Cardiac physiology

These rankings are truly outstanding, especially his top-tier placements in Diabetic Cardiomyopathy and Cardiac Physiology. To be ranked #2 in Diabetic Cardiomyopathy highlights his pioneering contributions to understanding and addressing heart disease in diabetic patients, a field of critical importance globally. His #5 ranking in Cardiac Physiology further underscores his profound impact on our fundamental understanding of heart function.

About ScholarGPS

ScholarGPS is revolutionizing how we measure academic influence. They provide the first fully quantitative rankings for over 30 million scholars and 120,000 research institutions across the globe. Their system spans 14 broad Fields, 177 Disciplines, and over 350,000 Specialties, ensuring a precise and unbiased evaluation of research impact.